
2.65 Delayed Data As of Dec 01 | ![]() Today’s Change | 1.63 Today|||52-Week Range 21.47 | -73.74% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $261.3M |
Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego California 92131 |
J. Scott Wolchko | President, Chief Executive Officer & Director |
Edward J. Dulac | Chief Financial Officer & Accounting Officer |
Bahram Valamehr | Chief Research & Development Officer |
Wen Bo Wang | Senior Vice President-Technical Operations |
Jim Beitel | Senior Vice President-Corporate Development |